M. DAVID MACFARLANE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TITAN PHARMACEUTICALS INC

Filing Date Source Excerpt
2016-06-29 The audit committee was formed in compliance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 (the “Exchange Act”) and currently consists of Joseph A. Akers, Ley S. Smith, M. David MacFarlane and Victor J. Bauer, each of whom meets the independence requirements and standards currently established by the Nasdaq and the SEC.
2018-12-20 M. David MacFarlane Fees Earned or Paid in Cash ($): $60,000 Total ($): $60,000
2023-05-19 The audit committee currently consists of M. David MacFarlane, Ph.D.... The compensation committee currently consists of M. David MacFarlane, Ph.D.... The nominating and governance committee consists of M. David MacFarlane, Ph.D.... M. David MacFarlane 2022 compensation total $70,109.

Data sourced from SEC filings. Last updated: 2026-02-03